Evidence map›Paper›PMID 27485435›Full record

ArticleBMC health services research2016

Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users.

Aimee N C Campbell, Don Des Jarlais, Cooper Hannah, Sarah Braunstein, Susan Tross, Laura Kersanske, Christine Borges, Martina Pavlicova, Kevin Jefferson, Howard Newville and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Aimee N C CampbellDepartment of Psychiatry, Columbia University Medical Center, New York State Psychiatric Institute, 1051 Riverside Drive, Box 120, New York, NY, 10032, USA. anc2002@cumc.columbia.edu.
Don Des JarlaisIcahn School of Medicine at Mount Sinai, 39 Broadway, 5th Floor, New York, NY, 10006, USA.
Cooper HannahDepartment of Behavioral Science and Health Education, Emory University, Rollins School of Public Health, 1518 Clifton Road NE, Room 568, Atlanta, GA, 30322, USA.
Sarah BraunsteinNew York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY, 11101, USA.
Susan TrossDepartment of Psychiatry, Columbia University Medical Center, New York State Psychiatric Institute, 1051 Riverside Drive, Box 120, New York, NY, 10032, USA.
Laura KersanskeNew York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY, 11101, USA.
Christine BorgesNew York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY, 11101, USA.
Martina PavlicovaDepartment of Biostatistics, Mailman School of Public Health, Columbia University, 722 West 168th Street, 6th Floor, #637, New York, NY, 10032, USA.
Kevin JeffersonDepartment of Behavioral Science and Health Education, Emory University, Rollins School of Public Health, 1518 Clifton Road NE, Room 568, Atlanta, GA, 30322, USA.
Howard NewvilleDepartment of Psychiatry and Behavioral Health, Mount Sinai St. Luke's Hospital, 1111 Amsterdam Avenue, 11th Floor, New York, NY, 10025, USA.
Laurel WeaverDepartment of Psychiatry and Behavioral Health, Mount Sinai St. Luke's Hospital, 1111 Amsterdam Avenue, 11th Floor, New York, NY, 10025, USA.
Margaret WolffDepartment of Psychiatry and Behavioral Health, Mount Sinai St. Luke's Hospital, 1111 Amsterdam Avenue, 11th Floor, New York, NY, 10025, USA.
St. Luke's Hospital · USNew York City Department of Health and Mental Hygiene · USEmory University · USColumbia University · USIcahn School of Medicine at Mount Sinai · USNew York State Psychiatric Institute

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2003 to 2026
$48.2M
Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Risk Factors for HIV/AIDS in Drug UsersR01DA003574 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C, MCKNIGHT, COURTNEY · 1986 to 2025
$16.2M
Evaluating ART for All HIV Seropositives: Can it work with the hardest cases?R01DA035707 · NIDA · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI CAMPBELL, AIMEE N, DES JARLAIS, DON C · 2013 to 2017
$3.1M
NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA003574NIDA NIH HHS R01 DA035707NIMH NIH HHS P30 MH043520
6 · The paper itself

Abstract

backgroundThe intersection of HIV-related health outcomes and problem substance use has been well documented. New York City continues to be a focal point of the U.S. HIV epidemic. In 2011, the NYC Department of Health and Mental Hygiene (NYC DOHMH) issued a recommendation that all HIV infected individuals should be offered antiretroviral therapy (ART) regardless of CD4 cell count or other indicators of disease progression. This policy is based in the concept of "treatment as prevention," in which providing ART to people living with HIV (PLWH) greatly reduces the likelihood of HIV transmission, while also improving individual health. The "ART for ALL" (AFA) study was designed to inform modifications to and identify gaps in the implementation of universal ART, and specifically to help guide allocation of resources to obtain local policy goals for increasing viral suppression among PLWH who have problem substance use. METHODS/

designThe AFA Study is informed by two complementary frameworks: Glasgow and colleagues' RE-AIM model, a multi-level framework developed to guide the evaluation of implementation of new policies, and Bronfrenbrenner's ecological systems model, which conceptualizes the bi-directional interplay between people and their environment. Using multi-level data and mixed methods, the primary aims of the AFA Study are to assess rates of viral load suppression, using the NYC HIV Surveillance Registry, within 12 months of HIV diagnosis with (a) yearly cohorts of high-risk-to-transmit, difficult-to-treat, substance using patients recruited from NYC Sexually Transmitted Disease clinics and a large detoxification unit and (b) yearly cohorts of all newly HIV diagnosed people in NYC. Further goals include (c) recruiting cross-sectional samples of HIV/AIDS service providers to assess ART initiation with problem substance users and d) examining geographic factors that influence rates of viral load suppression. An Implementation Collaborative Board meets regularly to guide study procedures and interpret results. DISCUSSION: The AFA Study has the unique strength of accessing and analyzing data at multiple levels using mixed methodology, taking advantage of NYC DOHMH biomedical surveillance data. If successful, others may benefit from lessons learned to inform local and state policies to improve the health of PLWH and further reduce HIV transmission.

Indexed as

Health PolicySubstance-Related DisordersAdolescentAdultAnti-Retroviral AgentsCD4 Lymphocyte CountCross-Sectional StudiesDisease ProgressionFemaleHIV InfectionsHumansMaleMiddle AgedNew York CityViral LoadYoung AdultAnti-Retroviral AgentsAdherenceAffordable care actAntiretroviral therapyHIV/AIDSSubstance use

Identifiers

PMID27485435
PMCPMC4971753
OpenAlexW2484593108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.